TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Takeda Pharma A/S
Closing information (x1000 NOK)
| Closing information | 2023/03 | 2022/03 | 2021/03 |
| Turnover |
1,613,834
|
1,176,937
|
2,609,578 |
| Earnings before taxes |
31,711
|
55,249
|
1,229,573 |
| Total assets |
738,707
|
804,783
|
2,714,256 |
| Current assets |
623,868
|
719,788
|
2,625,531 |
| Current liabilities |
570,697
|
679,731
|
1,281,737 |
| Equity capital |
144,307
|
105,061
|
1,408,117 |
| - share capital |
15,360
|
13,062
|
13,591 |
| Employees (average) |
350
|
350
|
350 |
Financial ratios
| Fiscal year | 2023/03 | 2022/03 | 2021/03 |
| Solvency |
19.5%
|
13.1%
|
51.9% |
| Turnover per employee |
4,611
|
3,363
|
7,456 |
| Profit as a percentage of turnover |
2.0%
|
4.7%
|
47.1% |
| Return on assets (ROA) | |||
| Current ratio |
109.3%
|
105.9%
|
204.8% |
| Return on equity (ROE) |
22.0%
|
52.6%
|
87.3% |
| Change turnover |
229,859
|
-1,330,983
|
497,413 |
| Change turnover % |
17%
|
-53%
|
24% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/03 | 2022/03 | 2021/03 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.